暂无中文版
该报道尚无中文版,以下为英文内容。
Post suggests new GLP-1 weight loss pills from Novo Nordisk and Eli Lilly may increase consumer demand but employer-sponsored health insurance may not cover them.
Finnhub06/26 21:08
相关资产
NVO 接下来的事件
继续探索
最新 NVO 新闻
MarketWatch08/27 15:37
Jin1008/27 10:33
Finnhub08/19 17:10